GrantExec

Grants for Native American tribal organizations - Health

Explore 2,728 grant opportunities

Broadband Digital Equity Capacity Grant Program 2025
$15,000,000
Indiana Broadband
State

Application Deadline

Jun 13, 2025

Date Added

May 2, 2025

This grant provides funding to various organizations in Indiana to promote digital equity and improve access to technology for underserved populations, including low-income households, seniors, veterans, and rural residents.

Education
City or township governments
NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Not Allowed)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Mar 6, 2025

Date Added

Dec 3, 2024

This funding opportunity supports early-career clinical scientists from diverse backgrounds in developing their research skills and addressing cancer health disparities through mentored research experiences in cancer-related fields.

Education
State governments
Implement and sustain a comprehensive response to HIV and technical assistance to strengthen the capacity of regional authorities in the United Republic of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR)
$50,000,000
U.S. Department of Health & Human Services (Centers for Disease Control-GHC)
Federal

Application Deadline

Mar 11, 2025

Date Added

Jul 26, 2024

This funding opportunity provides financial support to organizations working in Tanzania to improve HIV prevention and treatment services, strengthen local health systems, and promote health equity for people living with HIV.

Health
State governments
Institutional Translational Research Training Program (T32 - Clinical Trial Not Allowed)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Mar 26, 2025

Date Added

Feb 29, 2024

This grant provides funding to support advanced students and postdoctoral researchers in neuroscience, helping them gain the skills needed to translate basic research into clinical applications for neurological diseases.

Health
State governments
Research Opportunities in Crisis Response Services for Suicide Prevention (R01 Clinical Trial Optional)
$2,000,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Oct 8, 2025

Date Added

Jun 14, 2024

This funding opportunity supports research projects that evaluate and improve crisis response services for suicide prevention, targeting a wide range of eligible applicants including universities, nonprofits, and government entities.

Health
State governments
Research Project Grant (Parent R01 Clinical Trial Required)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Jan 7, 2025

Date Added

Dec 19, 2024

This funding opportunity supports research projects that include clinical trials aimed at improving health outcomes, targeting a wide range of eligible applicants such as universities, nonprofits, and for-profit organizations.

Education
State governments
Short Courses Promoting Cross-National Analyses Using Data from the International Health and Retirement Study (HRS) and Harmonized Cognitive Assessment Protocol (HCAP) (R25 Clinical Trial Not Allowed)
$350,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 1, 2024

Date Added

Aug 28, 2024

This grant provides funding for short courses that aim to enhance research skills in using cognitive data to study aging and Alzheimer's disease across different countries, ultimately improving health outcomes and informing policies.

Health
State governments
Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required)
$1,500,000
HHS-NIH11 (National Institutes of Health)
Federal

Application Deadline

Jul 8, 2024

Date Added

Mar 15, 2024

The purpose of this Notice of Funding Opportunity (NOFO) is to support collaborative, transdisciplinary, translational research projects which advance exceptionally promising, chemically complex botanical and other natural products relevant to dietary supplements towards highly informative clinical trials of their effects on quantitative, objective measures of human resilience. Dynamic, synergistic interactions among the range of experts required to ensure rigor in all aspects of this research will be supported by a multi-PD/PI team collaborating on a single set of integrated specific aims, culminating in data on optimal parameters for a future proposed clinical efficacy trial, as well as the development and validation of other critical knowledge and methods for interpretation of such a trial, such as clinical assessment of the engagement of an outcome-relevant target. Enhancing workforce and institutional capacity to conduct future rigorous, transdisciplinary research on chemically complex natural products must be built into the plans for research and for enhancing diverse perspectives. Achievement of the RM1 specific aims is expected to provide a strong foundation for a future highly informative clinical efficacy trial of the effects on resilience of a chemically complex natural product.This NOFO is one component of the Consortium Advancing Research on Botanicals and Other Natural Products (CARBON) Program. Other components of this Program include RFA-AT-24-008, Leveraging Data at Scale to Understand Natural Product Impacts on Whole Person Health (R01) and RFA-AT-24-007, Limited Competition: Research Resource for Natural Product Nuclear Magnetic Resonance Data (R24).

Health
State governments
Human Leukocyte Antigen (HLA) and Killer-cell Immunoglobulin-like Receptor (KIR) Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed)
$400,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Aug 20, 2024

Date Added

Apr 24, 2024

The purpose of this notice of funding opportunity (NOFO) is to support research that 1) defines associations between variations in human leukocyte antigen (HLA) and killer cell immunoglobulin-like receptor (KIR) genetic regions and immune-mediated diseases, 2) elucidates mechanisms underlying these associations with the goal of advancing therapeutic opportunities, and/or 3) validates association data in order to improve the predictive power of clinical disease screening.

Health
State governments
Notice of Intent to Publish a Funding Opportunity for The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12 Clinical Trial Optional)
Contact for amount
HHS-NIH11 (National Institutes of Health)
Federal

Application Deadline

Jun 17, 2024

Date Added

Sep 25, 2023

The National Cancer Institute (NCI) intends to publish a Notice of Funding Opportunity (NOFO), theNCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12). The NOFO will invite applications for institutional research career development programs to support the training of clinical scientists in community cancer prevention, intervention, and treatment research. Special emphasis is placed on training of clinical scientists whose career goal is to meet the needs of underserved or underrepresent ed communities for access to clinical care and participation in clinical research. The NOFO will allow the appointment ofScholars proposing to serve as the lead investigator of an independent community-based clinical trial; or proposing a separate ancillary study to an existing prevention, screening or control clinical trial; or proposing to gain research experience in a community-based clinical trial led by another investigator; or proposing to serve as leader of innovative clinical trial approaches that expand engagement of underserved or underrepresented communitiesin cancer clinical research, as part of their research and career development. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive applications. The NOFO is expected to be published in April 2024 with an expected application due date in June 2024. TheNOFO will utilize theK12 activity code for Clinical Scientist Institutional Career Development Program Awards. Details of the planned NOFO are provided below.

Health
Public and State controlled institutions of higher education
Advancing country-led sustainable digital health transformation across PEPFAR-supported countries through informatics workforce capacity development to end HIV/AIDS and TB as a public health threat by 2030 under PEPFAR
$25,000,000
U.S. Department of Health & Human Services (Centers for Disease Control-GHC)
Federal

Application Deadline

Feb 21, 2025

Date Added

Jul 19, 2024

This funding opportunity is designed to strengthen health informatics capabilities in PEPFAR-supported countries by developing a skilled workforce and enhancing digital health systems to combat HIV/AIDS and tuberculosis effectively.

Health
State governments
Population Genomic Screening in Primary Care Coordinating Center(U01 -Clinical Trials Optional)
$680,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Dec 2, 2024

Date Added

Aug 23, 2024

This funding opportunity supports higher education institutions, nonprofit organizations, for-profit organizations, and local governments in establishing a Coordinating Center to implement and evaluate population genomic screening in primary care, focusing on diverse communities and actionable genetic conditions.

Health
State governments
Health Financing and Public Financial Management Systems Strengthening Activity in South Africa
$30,000,000
U.S.AID-SAF (South Africa U.S.AID-Pretoria)
Federal
Rolling

Application Deadline

Not specified

Date Added

Dec 11, 2023

The United States Agency for International Development in Southern Africa (USAID/SouthernAfrica) is seeking Concept Papers from qualified entities to implement an activity entitledHealth Financing and Public Financial Management Systems Strengthening Activity in SouthAfrica. Eligibility for this award is not restricted. The authority for the Notice of FundingOpportunity (NOFO) is found in the Foreign Assistance Act of 1961, as amended.Subject to funding availability and at the discretion of the Agency, USAID intends to provide upto $30 million in total USAID funding over a five (5) year period through a CooperativeAgreement with the selected applicant. Eligible organizations interested in submitting a ConceptPaper are encouraged to read this NOFO thoroughly to understand the type of project sought(Section A), the application submission requirements (Sections C and D), and the evaluationprocess and merit review criteria (Section E). To be eligible for award, the applicant mustprovide all information required in this NOFO and meet eligibility standards in Section C.Concepts must be received by the date and time indicated at the top of this cover letter. Notethat USAID is not accepting full applications at this time - only Concept Papers.

Health
State governments
Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UH3 Clinical Trial Optional)
$400,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Oct 21, 2025

Date Added

Jun 10, 2025

This funding opportunity supports U.S. institutions conducting clinical trials on innovative regenerative medicine therapies using adult stem cells, focusing on extending research from previously funded projects.

Health
State governments
Notice of Intent to Publish a Funding Opportunity Announcement for NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Contact for amount
HHS-NIH11 (National Institutes of Health)
Federal

Application Deadline

Jul 2, 2024

Date Added

Mar 22, 2024

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) intend to publish a Notice of Funding Opportunity (NOFO) to solicit applications for large single or multisite clinical trials within the mission area of the institute. The NOFO is expected to be published in Spring 2024 with an expected application due date in Summer 2024. Only New, Resubmission and Revision applications will be eligible. This NOFO will utilize the UG3/UH3 phased cooperative agreement activity code. A UG3 milestone plan is required. Details of the planned NOFO are provided below.

Health
State governments
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Not Allowed)
$150,000
HHS-NIH11 (National Institutes of Health)
Federal

Application Deadline

May 7, 2024

Date Added

May 26, 2021

This Funding Opportunity Announcement (FOA) invites applications to enhance the pool of of highly trained investigators from diverse backgrounds , including those from groups underrepresented in research areas of interest to the NHLBI. The career development will take place under the guidance of an experienced mentor in the biomedical, behavioral or clinical sciences leading to research independence. It is targeted toward individuals whose basic, clinical, and translational research interests are grounded in the advanced methods and experimental approaches needed to solve problems related to cardiovascular, pulmonary, and hematologic diseases and sleep disorders in the general and health disparities populations. This FOA invites applications from Institutions with eligible faculty members to undertake special study and supervised research under a mentor who is an accomplished investigator in the research area proposed and has experience in developing independent investigators. This FOA is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial, as part of their research and career development. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary clinical trial as lead investigator, should apply to the companion FOA (see RFA-HL-22-010).

Health
State governments
Notice of Intent to Publish a Funding Opportunity Announcement for Advancing Vision Health Equity through Multi-level Interventions and Community-Engaged Research (R01 - Clinical Trial Optional)
$1,000,000
U.S. Department of Health & Human ServicesU.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Mar 3, 2025

Date Added

Dec 27, 2024

This funding opportunity supports research projects that develop and implement community-focused interventions to improve vision health outcomes and address disparities among underserved populations.

Health
State governments
Civil Money Penalty Communicative Technology Grant
$12,774,440
California Department of Public Health
State
Rolling

Application Deadline

Not specified

Date Added

May 21, 2024

This grant opportunity allows Skilled Nursing Facilities to apply for funding to purchase tablets and tablet-related accessories. Facilities must attest the tablets will be used for facilitating virtual telehealth or family visits for residents. Facilities must be certified through the Centers of Medicare and Medicaid Services (CMS). Applicants may generally request up to $3,000.00, however requests beyond $3,000.00 will be accepted and will require CDPH and CMS review. Applicants must use the template provided on the CDPH website; cover letters are not required. Keywords: Tablet, Communicative Technology, Skilled Nursing Facility, CMS, CDPH, CMP, Civil Money Penalty, Public Health, SNF

Health
Small businesses
Mechanistic Investigations into ADRD Associated Protein Structures in Biological Settings (R01 - Clinical Trial Not Allowed)
$500,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Oct 4, 2024

Date Added

Jun 11, 2024

The grant titled "Mechanistic Investigations into ADRD Associated Protein Structures in Biological Settings" aims to use recent advancements in structural biology to study protein assemblies related to Alzheimer's disease and related dementias (AD/ADRD) in their natural environments within cells and tissues, with the goal of developing ligands that can identify and monitor these proteins in patients.

Health
State governments
Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed)
$400,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Mar 3, 2025

Date Added

Dec 9, 2024

This funding opportunity supports the development of innovative computational tools to enhance the use of the human pangenome in genomic research, particularly for applications in cancer, aging, and diverse populations.

Education
State governments